Bergeson & Campbell, P.C. (B&C) and its consulting affiliates, B&C Consortia Management, L.L.C. (BCCM) and The Acta Group, L.L.C. (Acta), are pleased to announce the expansion of their capabilities in Asia. The Acta Group China, L.L.C. has formed a joint venture with Pacific Life Sciences Co. Ltd. (PLS), a leading Chinese firm serving the chemical industry with offices in Beijing, Shanghai, and Tanjin, China. This partnership broadens the firms' global capabilities in product stewardship and chemical control activities for conventional and nanoscale industrial, biocidal, and biobased chemical products.
'Our new joint venture, Acta-PLS, will allow us to build on our track record of helping our clients successfully market their chemical products by providing seamless service in all the key jurisdictions around the globe,' said Lynn Bergeson, President of Acta and Managing Principal of B&C. PLS is a leader in helping global chemical companies navigate the regulatory requirements in China, enabling it to access one of the world's largest and fastest growing markets. 'Acta and B&C are dedicated to helping their clients efficiently overcome regulatory impediments as chemical control jurisdictions expand around the world. Acta and PLS share a commitment to meeting our clients' growth goals, so we are delighted that we are joining forces,' said Leslie Scott MacDougall, Director of Regulatory Affairs for The Acta Group EU, Ltd and who will be significantly engaged in Acta-PLS matters.
Through the joint venture with PLS, Acta will expand its ability to offer notification, problem solving, advocacy, transportation, classification/GHS, and import/export support under chemical legislations in China for multinational companies with agrochemical, industrial chemical, biocide, and food contact needs.